BioWorld

Jan. 9, 2002

DeCode Adding Chemistry Via $83.6M MediChem Acquisition

Calling the move not only logical, but necessary, DeCode Genetics Inc. said it is buying MediChem Life Sciences Inc. in a stock swap worth about $83.6 million. Read More

Pharmacyclics: Xcytrin Works In Lung-Brain Metastasis Group

Iowa University, IntronnJoin To Correct Cystic Fibrosis Mutant Gene In Customized Mouse Mimic

IDEC Hits Manufacturing Snag With Zevalin; Trials Not Needed

Other News To Note

Signature Adding To Oncology Portfolio Via PrimeCyte Purchase

Enzon, Inhale Enter Broad Deal On Pegylation, Licensing, Lawsuit

Maxygen Partners With Celltech To Work On Antibody Programs

3-D Pharma In-Licenses Drug From GSK Through Stock Deal

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...